Tinubu has congratulated the National Agency for Food and Drug Administration and Control (NAFDAC) for successfully retaining the World Health Organisation’s (WHO) Maturity Level 3 (ML3) certification for the regulation of medicines and vaccines.
The achievement follows a re-benchmarking exercise conducted by the WHO from May 28 to May 30, 2025, which assessed NAFDAC against globally recognised standards for regulatory performance.
NAFDAC first attained the ML3 status in 2022, becoming Africa’s first National Regulatory Authority to achieve the milestone in the regulation of medicines and vaccines (non-producing). In line with WHO policy, periodic reviews are carried out to ensure continued compliance.
In a statement, Tinubu welcomed the WHO’s verdict that NAFDAC “has successfully maintained a regulatory system that operates as a stable, well-functioning, and integrated framework” for safeguarding the quality of medicines and vaccines.
He commended the agency’s management and staff for their professionalism and consistency in protecting public health.
The President described the milestone as a boost to Nigeria’s standing as a reliable partner in global health security and pandemic preparedness.
He reaffirmed his administration’s commitment to supporting NAFDAC in its quest to achieve WHO’s highest global standard — Maturity Level 4.
Tinubu added that the achievement aligns with his Renewed Hope Agenda to transform Nigeria’s healthcare system, improve primary health facilities, expand national health insurance coverage, and promote local manufacturing of essential healthcare products.
